Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

Clinical trial NCT06353906 · RECRUITING

Trial details

NCT number: NCT06353906
Sponsor: The Netherlands Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urologic Neoplasms Urogenital Neoplasms Male Urogenital Diseases Penile Cancer Penile Squamous Cell Carcinoma Locally Advanced Penile Carcinoma

Start date: 2024-08-13
Primary completion: 2026-10-14
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.